Continuous monitoring of glucose for Type 1 diabetes: OHTAC recommendation
Health Quality Ontario
Record ID 32018000189
English
Authors' recommendations:
Health Quality Ontario, under the guidance of the Ontario Health Technology Advisory
Committee, recommends publicly funding continuous glucose monitoring in patients with type 1
diabetes who are willing to use continuous glucose monitoring for the vast majority of the time
and who meet one or more of the following criteria:
• Severe hypoglycemia without an obvious precipitant, despite optimized use of insulin
therapy and conventional blood glucose monitoring
• Inability to recognize, or communicate about, symptoms of hypoglycemia
Details
Project Status:
Completed
Year Published:
2018
URL for published report:
http://www.hqontario.ca/Portals/0/Documents/evidence/reports/recommendation-continuous-monitoring-of-glucose-for-type-1-diabetes-en.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Blood Glucose
- Blood Glucose Self-Monitoring
- Diabetes Mellitus, Type 1
- Glucose
- Humans
Contact
Organisation Name:
Health Quality Ontario
Contact Address:
Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5
Contact Name:
EDSinfo@hqontario.ca
Contact Email:
OH-HQO_hta-reg@ontariohealth.ca
Copyright:
Health Quality Ontario (HQO)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.